You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 8, August 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Trial
 This Article
 •Full text
 •PDF
 •eFigures
 •Correction
 •CME Course for This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Glaucoma
 •Women's Health
 •Women's Health, Other
 •Articles for Residents
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Canadian Glaucoma Study

2. Risk Factors for the Progression of Open-angle Glaucoma

Balwantray C. Chauhan, PhD; Frederick S. Mikelberg, MD; A. Gordon Balaszi, MD; Raymond P. LeBlanc, CM, MD; Mark R. Lesk, MSc, MD; Graham E. Trope, MB, PhD; for the Canadian Glaucoma Study Group

Arch Ophthalmol. 2008;126(8):1030-1036.

Objective  To determine systemic and ocular risk factors for visual field progression in open-angle glaucoma.

Methods  In the Canadian Glaucoma Study, a multicenter prospective longitudinal study of 258 patients (131 men and 127 women; median age, 65.0 years), baseline systemic measures included assessment of peripheral vasospasm and markers for hematopathology, coagulopathy, and immunopathology. Patients were followed up at 4-month intervals with perimetry, optic disc imaging, and a standardized interventional protocol for intraocular pressure control. Univariate and proportional hazards models were used to identify factors that predicted progression.

Main Outcome Measure  Visual field progression with standard automated perimetry.

Results  Median follow-up was 5.3 years, with 167 patients (64.7%) completing 5 years or more and 67 patients (26.0%) completing 7 years or more. Abnormal baseline anticardiolipin antibody levels (hazard ratio [HR], 3.86; 95% confidence interval [CI], 1.60-9.31), higher baseline age (HR per year, 1.04; 95% CI, 1.01-1.07), female sex (HR, 1.94; 95% CI, 1.09-3.46), and higher mean follow-up intraocular pressure (HR per 1 mm Hg, 1.19; 95% CI, 1.05-1.36) before progression were associated with progression.

Conclusions  The Canadian Glaucoma Study identified 4 independent predictive factors for glaucomatous field progression.

Application to Clinical Practice  While confirming the importance of intraocular pressure in glaucoma progression, this study determined other risk factors that merit awareness.

Trial Registration  clinicaltrials.gov Identifier: NCT00262626


Author Affiliations: Departments of Ophthalmology and Visual Sciences, Dalhousie University, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia (Drs Chauhan and LeBlanc), and University of British Columbia, Vancouver General Hospital, Vancouver, British Columbia (Dr Mikelberg); Departments of Ophthalmology, McGill University, Royal Victoria Hospital, Montreal, Quebec (Dr Balaszi), and Université de Montréal (Dr Lesk); and Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario (Dr Trope) Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Determinants of the Optic Cup to Disc Ratio in an Asian Population: The Singapore Malay Eye Study (SiMES)
Nishani Amerasinghe, Tien Y. Wong, Wan-Ling Wong, Paul Mitchell, Sunny Y. Shen, Seng-Chee Loon, Seang-Mei Saw, Paul J. Foster, Tin Aung, and for the SiMES Study Group
Arch Ophthalmol. 2008;126(8):1101-1108.
ABSTRACT | FULL TEXT  

Finding Risks for Glaucoma
James D. Brandt
Arch Ophthalmol. 2008;126(8):1138-1139.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Finding Risks for Glaucoma
Brandt
Arch Ophthalmol 2008;126:1138-1139.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.